PRESS RELEASE
News
-
-
PRESS RELEASE
Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration (AMD) Animal Model Using FDA-Recognized Surrogate Endpoints
Telomir Pharmaceuticals reports positive preclinical results for oral drug Telomir-1 in age-related macular degeneration (AMD) model, showing vision restoration, retinal regeneration, and reduced oxidative stress -
PRESS RELEASE
Communiqué de presse : L’avantage de Beyfortus pour la santé publique renforcé par la première comparaison en situation réelle des programmes de vaccination infantile et maternelle contre le VRS
Beyfortus renforce la protection contre le VRS chez les nourrissons avec des taux d'efficacité élevés et durables, confirmés par une étude en situation réelle. Des données présentées à l'ESPID 2025 démontrent une réduction significative des hospitalisations -
PRESS RELEASE
Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs
Real-world comparison shows Beyfortus and RSVpreF immunization programs reduce infant RSV hospitalizations in Spain and UK. Beyfortus provides sustained protection against RSV with high efficacy and safety profile -
-
-
-
PRESS RELEASE
Amarc and Freeport Are Planning a Significant 2025 Drill Program in Their Joy District, Including at the High Grade Copper-Gold-Silver Aurora Discovery
Amarc Resources Ltd. announces collaboration with Freeport-McMoRan for 2025 drill program at high-grade Cu-Au-Ag AuRORA Deposit and other deposits in BC's JOY District -
PRESS RELEASE
Wellgistics Health Announces Preliminary Inclusion in the Russell 2000 and Russell 3000 Indexes
Wellgistics Health, Inc. (NASDAQ:WGRX) announced preliminary inclusion in the Russell 2000 and Russell 3000 Indexes, enhancing visibility and institutional interest. Company redefines medication distribution & fulfillment -
